Owens & Minor (OMI) Competitors $5.20 -0.14 (-2.53%) Closing price 03:59 PM EasternExtended Trading$5.29 +0.09 (+1.63%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. HSIC, MCK, COR, CAH, PAHC, TLRY, AHCO, BLFS, NEOG, and INMDShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Henry Schein (HSIC), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Phibro Animal Health (PAHC), Tilray Brands (TLRY), AdaptHealth (AHCO), BioLife Solutions (BLFS), Neogen (NEOG), and InMode (INMD). These companies are all part of the "medical" sector. Owens & Minor vs. Its Competitors Henry Schein McKesson Cencora Cardinal Health Phibro Animal Health Tilray Brands AdaptHealth BioLife Solutions Neogen InMode Owens & Minor (NYSE:OMI) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Do insiders & institutionals believe in OMI or HSIC? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend OMI or HSIC? Owens & Minor presently has a consensus price target of $7.63, indicating a potential upside of 46.49%. Henry Schein has a consensus price target of $76.67, indicating a potential upside of 11.42%. Given Owens & Minor's higher possible upside, research analysts clearly believe Owens & Minor is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 3 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.25Henry Schein 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has more volatility & risk, OMI or HSIC? Owens & Minor has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Does the media favor OMI or HSIC? In the previous week, Henry Schein had 15 more articles in the media than Owens & Minor. MarketBeat recorded 18 mentions for Henry Schein and 3 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 1.08 beat Henry Schein's score of 0.93 indicating that Owens & Minor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 9 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, OMI or HSIC? Henry Schein has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.70B0.04-$362.69M-$15.63-0.33Henry Schein$12.67B0.66$390M$3.1022.20 Is OMI or HSIC more profitable? Henry Schein has a net margin of 3.05% compared to Owens & Minor's net margin of -13.78%. Owens & Minor's return on equity of 26.59% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-13.78% 26.59% 2.45% Henry Schein 3.05%14.36%5.52% SummaryHenry Schein beats Owens & Minor on 10 of the 17 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$412.48M$10.84B$5.79B$21.54BDividend YieldN/A1.88%5.73%3.50%P/E Ratio-0.3313.9156.1427.48Price / Sales0.0430.42538.2852.65Price / Cash0.6025.0025.8118.13Price / Book0.713.4313.254.65Net Income-$362.69M$210.63M$3.29B$999.94M7 Day Performance-2.80%-0.87%0.47%0.79%1 Month Performance-8.04%1.65%4.60%4.54%1 Year Performance-66.48%-11.60%73.42%16.77% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.6894 of 5 stars$5.21-2.5%$7.63+46.5%-65.9%$412.48M$10.70B-0.3323,200Positive NewsShort Interest ↑HSICHenry Schein3.8249 of 5 stars$67.74-2.4%$76.67+13.2%-1.9%$8.42B$12.67B21.8525,000MCKMcKesson4.6302 of 5 stars$696.53+1.3%$725.10+4.1%+37.1%$85.50B$359.05B27.7745,000Positive NewsCORCencora4.8412 of 5 stars$297.64+1.8%$311.25+4.6%+26.2%$56.71B$293.96B30.6246,000Positive NewsHigh Trading VolumeCAHCardinal Health4.9564 of 5 stars$150.29+0.5%$165.93+10.4%+34.6%$35.71B$222.58B23.3057,700Positive NewsPAHCPhibro Animal Health4.4421 of 5 stars$39.43-0.1%$28.40-28.0%+80.2%$1.60B$1.30B18.882,475Analyst RevisionTLRYTilray Brands2.8538 of 5 stars$1.12-5.9%$1.94+73.0%-35.6%$1.31B$821.31M0.002,842AHCOAdaptHealth3.8111 of 5 stars$9.42-0.9%$13.40+42.3%-14.8%$1.29B$3.26B18.2910,500Positive NewsBLFSBioLife Solutions2.9451 of 5 stars$26.22-0.9%$31.29+19.3%+1.6%$1.27B$82.25M-218.48440News CoveragePositive NewsNEOGNeogen3.2609 of 5 stars$5.66-1.6%$7.50+32.5%-65.9%$1.25B$894.66M-1.132,110INMDInMode3.0668 of 5 stars$15.28+2.0%$18.04+18.1%-13.0%$946.87M$394.82M6.19480Positive News Related Companies and Tools Related Companies Henry Schein Alternatives McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Phibro Animal Health Alternatives Tilray Brands Alternatives AdaptHealth Alternatives BioLife Solutions Alternatives Neogen Alternatives InMode Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMI Stock Alerts